Novonix files 6-K on critical operational milestone

Novonix Limited filed a Form 6-K as a foreign private issuer, mainly to provide investors with an attached ASX announcement titled “NOVONIX Achieves Critical Operational Milestone” dated October 15, 2025.

Accepted by SEC EDGAR 10/16/2025 - 05:17 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Novonix Limited filed a Form 6-K as a foreign private issuer, mainly to provide investors with an attached ASX announcement titled “NOVONIX Achieves Critical Operational Milestone” dated October 15, 2025. The report is signed by the company’s Chief Financial Officer, Robert Long, indicating this operational milestone is significant enough to be formally furnished to U.S. markets, although specific details are contained in the referenced exhibit.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Novonix Limited (NVX) report in this Form 6-K?

The Form 6-K from Novonix Limited furnishes an ASX announcement titled “NOVONIX Achieves Critical Operational Milestone,” making this information available to U.S. investors.

What is the key exhibit in Novonix (NVX) October 2025 Form 6-K?

The key exhibit is Exhibit 99.1, an ASX announcement titled “NOVONIX Achieves Critical Operational Milestone” dated October 15, 2025.

Who signed Novonix Limited’s October 2025 Form 6-K?

The Form 6-K was signed on behalf of Novonix Limited by Robert Long, the company’s Chief Financial Officer.

When is the ASX announcement in Novonix’s Form 6-K dated?

The attached ASX announcement, listed as Exhibit 99.1, is dated October 15, 2025.

What type of issuer is Novonix Limited in this SEC filing?

Novonix Limited files this report as a foreign private issuer using Form 6-K under the Securities Exchange Act of 1934.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE

SECURITIES EXCHANGE ACT OF 1934

For the month of October, 2025

001-41208

(Commission File Number)

NOVONIX LIMITED

(Translation of registrant’s name into English)

Level 38

71 Eagle Street

Brisbane, QLD 4000 Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20‑F or Form 40‑F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

EXHIBIT INDEX

Exhibit No.		Description
Exhibit 99.1		ASX Announcement (NOVONIX Achieves Critical Operational Milestone) dated October 15, 2025.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

NOVONIX LIMITED
By:		/s/ Robert Long
		Robert Long
		Chief Financial Officer

Date: October 17, 2025